ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

Henderson Committee Final Recommendation Made On P01s

February 10, 1984

Former NCAB chairman, President’s Cancer Panel member Paul Calabresi dead at 73.

October 31, 2003

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

September 28, 2001

Richard Pestell To Lead Lombardi Cancer Cente

September 6, 2002

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013